Publications by authors named "Elyse Kharbanda"

Background: Electronic health record (EHR) data are an underused source for lactation-related research. The validity of ICD-10-CM-coded lactational mastitis is unknown.

Methods: We assessed lactational mastitis diagnosis code validity by medical record review.

View Article and Find Full Text PDF

Introduction: Intellectual and Developmental Disabilities (IDD) have been associated with high cardiometabolic risk in adults, but there is little data on youth. This study describes the prevalence of cardiometabolic risk factors among pediatric patients with and without IDD receiving care in a large, primarily rural health system.

Methods: This was a retrospective cohort study of patients aged 6-17 years with an index visit from August 1, 2022, to July 31, 2023, at one of 44 primary care clinics in a Midwestern health system.

View Article and Find Full Text PDF
Article Synopsis
  • The HealthPartners' Vaccine Safety Datalink team is using information from a Minnesota vaccination database to track vaccine safety better.
  • They checked how many vaccines were recorded from this new source compared to older ones and found that a lot were only tracked through the Minnesota system.
  • This helps them monitor the safety of both new and common vaccines more effectively, making sure more people’s vaccination records are up to date.
View Article and Find Full Text PDF

Background: Previous studies have found that exposure to childhood environmental stress is associated with cardiometabolic risk. However, it is not known whether individual health behaviors disrupt this relationship. This study prospectively evaluated the relationship between cumulative environmental stress in a low-income sample and cardiometabolic risk in middle childhood and examined whether child health behaviors attenuated this relationship.

View Article and Find Full Text PDF

Importance: COVID-19 vaccination is recommended throughout pregnancy to prevent pregnancy complications and adverse birth outcomes associated with COVID-19 disease. To date, data on birth defects after first-trimester vaccination are limited.

Objective: To evaluate the associated risks for selected major structural birth defects among live-born infants after first-trimester receipt of a messenger RNA (mRNA) COVID-19 vaccine.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the potential link between COVID-19 vaccination during pregnancy and the risk of stillbirth, addressing concerns of vaccine hesitancy among pregnant individuals.
  • A matched case-control approach was used, analyzing data from 276 confirmed stillbirths and 822 live births to assess any significant associations with vaccination status.
  • Results indicated no significant association between COVID-19 vaccination and stillbirth risk, regardless of vaccine type, number of doses, or timing of vaccination, suggesting that vaccination does not increase the risk of stillbirth in pregnant individuals.
View Article and Find Full Text PDF
Article Synopsis
  • - This study aimed to assess whether getting vaccinated with mRNA COVID-19 vaccines during pregnancy affects the risk of adverse pregnancy outcomes like preterm birth and small-for-gestational age infants.
  • - Researchers analyzed data from over 55,000 individuals with live singleton pregnancies and found that 42.3% received one or two doses of the vaccine, with the vaccination rate varying across maternal demographics.
  • - The results indicated that vaccinated individuals had a lower risk of preterm birth compared to unvaccinated individuals, but the vaccination did not significantly impact the risks of small-for-gestational age infants, gestational diabetes, gestational hypertension, or preeclampsia.
View Article and Find Full Text PDF

The human papillomavirus (HPV) vaccine can prevent HPV-related oropharyngeal cancers. Dental practitioners are uniquely positioned to promote HPV vaccines during routine dental care but experience barriers to doing so. Qualitative interviews were conducted with dental practitioners to understand barriers and inform intervention strategies to promote HPV vaccines.

View Article and Find Full Text PDF

Objective: To prospectively evaluate the relationship between cumulative environmental stress and cardiometabolic risk in middle childhood, and to examine whether hair cortisol, a measure of hypothalamic pituitary adrenal-axis activity, mediates this relationship.

Methods: In a cohort of children from low-income households (n = 320; 59% Hispanic, 23% Black, body mass index (BMI) percentile >50th at enrollment), environmental stressors including family and neighbourhood factors representing disadvantage/deprivation, and cortisol concentrations from hair samples, were measured over five timepoints beginning when children were 2-4 years old. Cardiometabolic risk factors (i.

View Article and Find Full Text PDF

Objective: To assess the validity of electronic health record (EHR)-based influenza vaccination data among adults in a multistate network.

Methods: Following the 2018-2019 and 2019-2020 influenza seasons, surveys were conducted among a random sample of adults who did or did not appear influenza-vaccinated (per EHR data) during the influenza season. Participants were asked to report their influenza vaccination status; self-report was treated as the criterion standard.

View Article and Find Full Text PDF

Background: Breastfeeding information stored within electronic health records (EHR) has recently been used for pharmacoepidemiological research, however the data are primarily collected for clinical care.

Objectives: To characterise breastfeeding information recorded in structured fields in EHR during infant and postpartum health care visits, and to assess the validity of lactation status based on EHR data versus maternal report at research study visits.

Methods: We assessed breastfeeding information recorded in structured fields in EHR from one health system for a subset of 211 patients who were also enrolled in a study on breast milk composition between 2014 and 2017 that required participants to exclusively breastfeed their infants until at least 1 month of age.

View Article and Find Full Text PDF

Background: Screening for risk behaviors is a routine and essential component of adolescent preventive health visits. Early identification of risks can inform targeted counseling and care. If stored in discrete fields in the electronic health record (EHR), adolescent screening data can also be used to understand risk behaviors across a clinic or health system or to support quality improvement projects.

View Article and Find Full Text PDF

Maternal smoking during pregnancy (MSDP) is associated with lower birth weight, childhood obesity, and elevated blood pressure (BP) in offspring. We aimed to examine whether birth weight and body mass index (BMI) mediate the effect of MSDP on BP in children. The study included 14,713 children aged 8 to 15 years from the National Health and Nutrition Examination Surveys from 1999 to 2018.

View Article and Find Full Text PDF

Objective: To describe changes in blood pressure (BP) and body mass index (BMI) associated with stimulant medication fills in children.

Methods: Observational, retrospective matched cohort study of children 6-17.9 years initiating stimulant medication between 7/1/2010-6/30/2017 matched 1:3 by age, race, ethnicity, and sex to children with no stimulant use during this period.

View Article and Find Full Text PDF
Article Synopsis
  • A study examined influenza vaccination coverage among pregnant people in the U.S. from the 2016-2017 to 2021-2022 seasons, revealing trends among different demographics.
  • Coverage rose from 63.0% in 2016-2017 to a peak of 71.0% in 2019-2020 but dropped significantly to 56.4% during the 2021-2022 season post-COVID-19 pandemic.
  • The research highlighted that the lowest vaccination rates were consistently among pregnant individuals aged 18-24 and non-Hispanic Black individuals, emphasizing the need for targeted outreach to increase vaccination coverage.
View Article and Find Full Text PDF
Article Synopsis
  • Early detection of hypertension in children is vital for reducing long-term heart disease risk, but it's often missed; the PedsBP tool aims to improve recognition by clinicians in a rural health system.
  • The study evaluates PedsBP's effectiveness in identifying hypertension in youth aged 6-17, comparing low-intensity and high-intensity implementation strategies.
  • The ongoing trial involves 40 clinics and focuses on measuring repeat hypertension readings and awareness of the condition, with results anticipated in mid-2024.*
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to estimate the prevalence of prescription medication use among lactating mothers at 2, 4, and 6 months postpartum using electronic health record data.
  • Researchers analyzed data from a US health system, linking mothers who received prenatal care to their infants' well-child visits to determine lactation status based on breast milk feeding.
  • Results showed that 69.2% of mothers were lactating at the 2-month visit, with the most commonly prescribed medications being progestin contraceptives, antidepressants, and antibiotics, which were also prevalent at later visits.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the potential link between COVID-19 booster vaccinations during pregnancy and the risk of spontaneous abortion, addressing concerns about vaccine safety among pregnant individuals.
  • Conducted across eight health systems, the research analyzed data from 112,718 unique pregnancies to evaluate outcomes based on vaccination timing and other factors such as maternal age and race.
  • Findings aim to clarify the safety of receiving mRNA COVID-19 booster shots during early pregnancy, which is crucial for increasing vaccination adherence within this population.
View Article and Find Full Text PDF
Article Synopsis
  • A study involving over 80,000 pregnant individuals found that receiving a COVID-19 mRNA booster shot did not increase the risk of serious health issues like thrombocytopenia, myocarditis, or stroke shortly after vaccination.
  • However, the booster was linked to a higher incidence of mild symptoms such as malaise or fatigue within the first week, and lymph node swelling or inflammation in the following weeks.
  • Overall, the results align with previous studies and suggest that it's safe for pregnant people to receive the COVID-19 booster.
View Article and Find Full Text PDF

Introduction: An increased risk of chorioamnionitis in people receiving tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine during pregnancy has been reported. The importance of this association is unclear as additional study has not demonstrated increased adverse infant outcomes associated with Tdap vaccination in pregnancy.

Methods: We conducted a retrospective observational cohort study of pregnant people ages 15-49 years with singleton pregnancies ending in live birth who were members of 8 Vaccine Safety Datalink (VSD) sites during October 2016-September 2018.

View Article and Find Full Text PDF
Article Synopsis
  • * Initial results suggested a protective effect of vaccination against SAB within certain time periods, but this effect diminished when extending the observation to later dates.
  • * The findings indicate that the timing and method of surveillance significantly influence the perceived relationship between vaccination and SAB, with no clear association observed when using a time-dependent model.
View Article and Find Full Text PDF

Background: Although results from studies of first-trimester influenza vaccination and congenital heart defects (CHDs) have been reassuring, data are limited for specific CHDs.

Methods: We assessed associations between reported maternal influenza vaccination, 1 month before pregnancy (B1) through end of third pregnancy month (P3), and specific CHDs using data from a multisite, population-based case-control study. Analysis included 2,982 case children diagnosed with a simple CHD (no other cardiac involvement with or without extracardiac defects) and 4,937 control children without a birth defect with estimated delivery dates during 2006-2011.

View Article and Find Full Text PDF

Recombinant zoster vaccine (RZV) (Shingrix; GlaxoSmithKline, Brentford, United Kingdom) is an adjuvanted glycoprotein vaccine that was licensed in 2017 to prevent herpes zoster (shingles) and its complications in older adults. In this prospective, postlicensure Vaccine Safety Datalink study using electronic health records, we sequentially monitored a real-world population of adults aged ≥50 years who received care in multiple US Vaccine Safety Datalink health systems to identify potentially increased risks of 10 prespecified health outcomes, including stroke, anaphylaxis, and Guillain-Barré syndrome (GBS). Among 647,833 RZV doses administered from January 2018 through December 2019, we did not detect a sustained increased risk of any monitored outcome for RZV recipients relative to either historical (2013-2017) recipients of zoster vaccine live, a live attenuated virus vaccine (Zostavax; Merck & Co.

View Article and Find Full Text PDF